Ironwood Pharmaceuticals and Forest Laboratories have launched a campaign to get patients with irritable bowel syndrome with constipation or chronic ideopathic constipation to talk about their symptoms.
Two recent consumer campaigns for prescription weight-loss medications show that marketers are seeking to gain mindshare using the same tonality and talking points as non-prescription interventions.
Stage 1 of the three stages of meaningful use criteria has ended, and Stage 2 is rolling out. So far, it’s unclear if the incentives improve patient care. How can industry help doctors bridge the quality gap through EHRs?
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix